BiodentineTM versus formocresol pulpotomy technique in primary molars: a 12–month randomized controlled clinical trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Erdem A, Guven Y, Balli B, Ilhan B, Sepet E, Ulukapi I, Aktoren O. Success rates of mineral trioxide aggregate, ferric sulfate and formocresol pulpotomies: a 24–month study. Pediatr Dent. 2011;33:165–70.
American Academy of Pediatric Dentistry. Pulp therapy for primary and immature permanent teeth. Pediatr Dent. 2018;40:343–51.
Srinivasan V, Patchett CL, Waterhouse PJ. Is there life after Buckley's formocresol? Part I – a narrative review of alternative interventions and materials. Int J Paediatr Dent. 2006;16:117–27.
Athanassiadis B, George GA, Abbott PV, Wash LJ. A review of the effects of formaldehyde release from endodontic materials. Int Endod J. 2015;48:829–38.
American Academy of Pediatric Dentistry. Pulp therapy for primary and immature permanent teeth. Pediatr Dent. 2017;39:325–33.
Zanini M, Sautier J, Berdal A, Simon S. BiodentineTM induces immortalized murine pulp cell differentiation into odontoblast–like cells and stimulates biomineralization. J Endod. 2012;38:1220–6.
Bani M, Elif S, Odabas ME. Efficacy of BiodentineTM as an apical plug in nonvital permanent teeth with open apices: an in vitro study. BioMed Research International. 2015;2015:359275.
Yoldaş SE, Bani M, Atabek D, Bodur H. Comparison of the potential discoloration effect of Bioaggregate, BiodentineTM, and white mineral trioxide aggregate on bovine teeth: in vitro research. J Endod. 2016;42:1815–8.
Bhavya B, Sadique M, Simon EP, Ravi SV, Lal S. Spectrophotometric analysis of coronal discoloration induced by white mineral trioxide aggregate and BiodentineTM: an in vitro study. J Conserv Dent. 2017;20:237–40.
Shamkhalov GS, Ivanova EV, Dmitrieva NA, Akhmedova ZR. Comparative study of antimicrobial activity of "BiodentineTM " and "Rootdent" cements and "Futurabond NR" adhesive. J Stomato. 2013;92:37–9.
Han L, Okiji T. Bioactivity evaluation of three calcium silicate–based endodontic materials. Int Endod J. 2013;46:808–14.
Nowicka A, Lipski M, Parafiniuk M, Sporniak–Tutak K, Lichota D, Kosierkiewicz A, Kaczmarek W, Buczkowska–Radlińska J. Response of human dental pulp capped with BiodentineTM and mineral trioxide aggregate. J Endod. 2013;39:743–7.
Bani M, Aktaş N, Çınar Ç, Odabaş ME. The clinical and radiographic success of primary molar pulpotomy using Biodentine™ and mineral trioxide aggregate: a 24-month randomized clinical trial. Pediatr Dent. 2017;39:284–8.
Niranjani K, Prasad MG, Vasa AA, Divya G, Thakur MS, Saujanya K. Clinical evaluation of success of primary teeth pulpotomy using mineral trioxide aggregate(®), laser and Biodentine(TM) – an in vivo study. J Clin Diagn Res. 2015;9:ZC35–7.
Cuadros-Fernández C, Lorente Rodríguez AI, Sáez-Martínez S, García-Binimelis J, About I, Mercadé M. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and BiodentineTM: a randomized clinical trial. Clin Oral Investig. 2016;20:1639–45.
Juneja P, Kulkarni S. Clinical and radiographic comparison of BiodentineTM , mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars. Eur Arch Paediatr Dent. 2017;18:271–8.
Agamy H, Bakry N, Mounir M, Avery D. Comparison of mineral trioxide aggregate and formocresol as pulp–capping agents in pulpotomized primary teeth. Pediatr Dent. 2004;26:302–9.
Farsi N, Alamoudi N, Balto K, Mushayt A. Success of mineral trioxide aggregate in pulpotomized primary molars. J Clin Pediatr Dent. 2005;29:307–11.
Sushynski J, Zealand C, Botero TM, Boynton JR, Majewski RF, Shelburne CE, Hu JC. Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6– to 24–month observation. Pediatr Dent. 2012;34:120–8.
Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Int J Surg. 2011;9:672–7.
Sonmez D, Sari S, Cetinbas T. A comparison of four pulpotomy techniques in primary molars: a long-term follow–up. J Endod. 2008;41:547–55.
Fuks A, Bimstein E, Klein H, Guelmann M. Assessment of a 2% buffered glutaraldehyde solution in pulpotomized primary teeth of school children. J Dent Child. 1990;57:371–5.
Kusum B, Rakesh K, Richa K. Clinical and radiographical evaluation of mineral trioxide aggregate, BiodentineTM and propolis as pulpotomy medicaments in primary teeth. Restor Dent Endod. 2015;40:276–85.
Smaïlfaugeron V, Porot A, Mullerbolla M, Courson F. Indirect pulp capping versus pulpotomy for treating deep carious lesions approaching the pulp in primary teeth:a systematic review. Eur J Paediatr Dent. 2016;17:107–12.
Chandrashekhar S, Shashidhar J. Formocresol, still a controversial material for pulpotomy: a critical literature review. J Res Dent. 2014;2:114–24.
Bakland LK. Management of traumatically injured pulps in immature teeth using MTA. J Calif Dent Assoc. 2000;28:855–8.
Schwendicke F, Brouwer F, Stolpe M. Calcium hydroxide versus mineral trioxide aggregate for direct pulp capping: a cost–effectiveness analysis. J Endod. 2015;41:1969–74.
Coll JA, Seale NS, Vargas K, Marghalani AA, Al Shamali S, Graham L. Primary tooth vital pulp therapy: a systematic review and meta–analysis. Pediatr Dent. 2017;39:16–123.
Rubanenko M, Moskovitz M, Petel R, Fuks A. Effectiveness of BiodentineTM versus formocresol as dressing agents in pulpotomized primary molars: preliminary results. Sopot, Poland: 12th congress of EAPD; 2014.
Priyalakshmi S, Ranjan M. Review on BiodentineTM–a bioactive dentin substitute. J Dent Med Sci. 2014;13:13–7.
Reddy MS. Radiographic methods in the evaluation of periodontal therapy. J Periodontol. 1992;63:1078–84.
Holan G, Eidelman E, Fuks A. Long–term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatr Dent. 2005;27:129–36.
Jabbarifar S, Khademi A, Ghasemi D. Success rate of formocresol versus mineral trioxide aggregate in human primary molar tooth. J Res Med Sci. 2004;6:55–8.
Awawdeh L, Al-Qudah A, Hamouri H, Chakra RJ. Outcomes of vital pulp therapy using mineral trioxide aggregate or BiodentineTM: a prospective randomized clinical trial. J Endod. 2018;44:1603–9.
Rajasekharan S, Martens LC, Vandenbulcke J, Jacquet W, Bottenberg P, Cauwels RG. Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. Int Endod J. 2017;50:215–28.
Zealand C, Briskie D, Botero T, Boynton J, Hu J. Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatr Dent. 2010;32:393–9.